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The primary cilium is a ubiquitous, microtubule-based organelle that cells utilize to
transduce molecular signals. Ciliopathies are a group of diseases that are caused by
a disruption in the structure or function of the primary cilium. Over 30% of all ciliopathies
are primarily defined by their craniofacial phenotypes, which typically include midfacial
defects, cleft lip/palate, micrognathia, aglossia, and craniosynostosis. The frequency
and severity of craniofacial phenotypes in ciliopathies emphasizes the importance of
the cilium during development of the craniofacial complex. Molecularly, many ciliopathic
mutants, including the avian talpid2 (ta2), report pathologically high levels of full-length
GLI3 (GLI3FL), which can go on to function as an activator (GLIA), and reduced production
of truncated GLI3 (GLI3T), which can go on to function as a repressor (GLIR). These
observations suggest that the craniofacial phenotypes of ciliary mutants like ta2 are
caused either by excessive activity of the GLIA or reduced activity of GLIR. To decipher
between these two scenarios, we examined GLI3 occupation at the regulatory regions
of target genes and subsequent target gene expression. Using in silico strategies we
identified consensus GLI binding regions (GBRs) in the avian genome and confirmed
GLI3 binding to the regulatory regions of its targets by chromatin immunoprecipitation
(ChIP). In ta2 mutants, there was a strikingly low number of GLI3 target genes that had
significantly increased expression in facial prominences compared to the control embryo
and GLI3 occupancy at GBRs associated with target genes was largely reduced. In vitro
DNA binding assays, further supported ChIP results, indicated that the excessive GLI3FL
generated in ta2 mutants did not bind to GBRs. In light of these results, we explored
the possibility of GLI co-regulator proteins playing a role in regulatory mechanism
of GLI-mediated transcription. Taken together our studies suggest that craniofacial
ciliopathic phenotypes are produced via reduced GLIT production, allowing for target
gene transcription to be mediated by the combinatorial code of GLI co-regulators.
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INTRODUCTION
Primary cilia are ubiquitous organelles that serve as cellular hubs
for transduction of numerous signaling pathways. Most notably,
cilia have been identified as transducers of the Hedgehog (Hh)
pathway. Identification of the primary cilium as a signaling hub
for the Hh pathway came from seminal experiments reporting
that anterograde and retrograde intraflagellar transport (IFT)
proteins in the cilium are required for Sonic Hedgehog (SHH)
signal propagation (Huangfu et al., 2003; Huangfu andAnderson,
2005). When SHH ligand is present, it binds to its receptor
Patched (PTCH), thus allowing Smoothened (SMO) to localize
and accumulate in the primary cilium (Corbit et al., 2005; Rohatgi
et al., 2007). Activated, ciliary SMO, in concert with Kif7, then
promotes the dissociation of GLI from Suppressor of Fused
(SUFU) (Humke et al., 2010; Tukachinsky et al., 2010; Li et al.,
2012) and the subsequent post-translational processing of GLI
proteins necessary for their function as activators and repressors
(Goetz and Anderson, 2010).
In vertebrates, there are three members of the GLI
transcription factor family: GLI1, GLI2, and GLI3. GLI1 and
GLI2 are considered transcriptional activators, whereas GLI3
mostly behaves as a repressor. However, there have been
examples of GLI2 functioning as a repressor in the absence of
GLI3, andGLI3 functioning as an activator in the absence of GLI2
(Mo et al., 1997; Theil et al., 1999; Tole et al., 2000; Bai and Joyner,
2001; Persson et al., 2002; Rallu et al., 2002; Buttitta et al., 2003;
Motoyama et al., 2003; Bai et al., 2004; Lei et al., 2004;McDermott
et al., 2005; Pan et al., 2009). Full-length GLI2 and GLI3 can
be processed via phosphorylation and other post-translational
modifications into the activator isoform (GLIA) or truncated
into the repressor isoform (GLIR) (Wang et al., 2000; Pan et al.,
2006). Inhibition of GLI processing prevents production of GLIA
and GLIR isoforms. Thus, an essential role of primary cilia is to
establish the ratio of GLIA to GLIR proteins (Haycraft et al., 2005;
Liu et al., 2005), which in turn controls transcription of SHH
target genes.
Three basic models have been proposed to depict the potential
mechanism of how SHH target genes are activated by a
gradient of GLI isoforms: (1) the ratio sensing model, (2) the
threshold repression model and (3) the threshold activation
model (Falkenstein and Vokes, 2014). Ratio sensing, as the name
implies, is based on the ratio of GLIA and GLIR rather than
concentration of either. The net balance of GLIA to GLIR then
determines if, and the extent to which, a target is activated
or repressed. The other two models suggest threshold-specific
mechanisms. The threshold activation model suggests that SHH
targets are activated when GLIA reaches a threshold-specific
concentration. On the other hand, in the threshold repression
model (de-repression), the activation of SHH target genes is
dictated by the alleviation of repression via loss of GLIR.
The talpid2 (ta2) is a naturally occurring avian mutant that
is best characterized by severe polydactyly and its oral-facial
phenotype (Abbott et al., 1959, 1960; Dvorak and Fallon, 1991;
Schneider et al., 1999). The face of affected ta2 embryos is
characterized by a dysmorphic frontonasal prominence, facial
clefting, hypoplastic maxillary prominences, incomplete fusion
of the primary palate and hypoglossia (Chang et al., 2014).
Our recent work determined that the ta2 mutation affected
ciliogenesis via a 19 bp deletion in C2CD3 (Brugmann et al.,
2010; Chang et al., 2014), a centriolar protein required for
ciliogenesis (Hoover et al., 2008). Our studies also determined
that the ta2 mutant genetically, biochemically and phenotypically
phenocopied the human craniofacial ciliopathy, Oral-facial-
digital syndrome 14 (OFD14) (Schock et al., 2015). ta2 embryos,
similar to many other ciliopathies, have a significant increase
in GLI3FL and a reduction in the amount GLIT (Chang et al.,
2014). However, the mechanism by which this disruption in
GLI isoform production affects expression of GLI targets in the
developing craniofacial complex remains unknown.
Herein, we utilize a combination of several biochemical
techniques to determine the impact loss of cilia has on GLI
function. Specifically, we examine the expression of GLI target
genes and occupation of GLI binding regions (GBRs) associated
with those targets in the developing frontonasal, maxillary and
mandibular prominences (FNP, MXP, and MNP, respectively)
in order to uncover the mechanism by which GLI mediated
transcription is being impacted in ta2 mutants. Understanding
the full extent of molecular disruptions in ta2 mutants will
hopefully guide future therapeutic strategies for craniofacial
ciliopathies, a rapidly growing group of disorders that currently
have little to no therapeutic treatment.
MATERIALS AND METHODS
Embryo Preparation
talpid2 (ta2) heterozygous carriers were mated, eggs were
collected and shipped from the UC Davis Avian Sciences
Department. Embryos were incubated at 37
◦
C for approximately
5–7 days when embryos reached Hamburger Hamilton stage
25–31 (HH25-31).
Quantitative RT-PCR of GLI Targets
FNPs, MXPs, and MNPs were harvested from day 5 chick
embryos. mRNA was prepared with TRIzol reagent (Thermo
Fisher Scientific), and then converted to complementary DNA
through reverse transcription reaction (High-Capacity cDNA
Reverse Transcription Kit, Applied Biosystems
TM
). Different
amounts of cDNA (40, 20, 10 and 5 ng) was used for quantitative
PCR to test PCR efficiency and a linear range of duplication
(SsoAdvanced
TM
Universal SYBR R© Green Supermix, BioRad).
Expression of genes known to play a role in craniofacial
development were examined with the following primer
sets: ALX4 (105 bp) F: GTTACGGTAAGGAGAGCAGTTT,
R:CTTTCACTCCAGCCTCCTTC, BMPR1A (100 bp) F:
GTGCTGTCGGACTGATTTCT, R:TGCCATCCAACGAAT
GCT, WIF1 (100 bp) F: CAACCTGTTTCAATGGAGGAAC,
R: GGCTGATGGCATTTACTGATTT, OSR2 (140 pb) F:
CCACTTCACCAAGTCCTACAA, R: TCTCTTTGGAATGGAT
GTACCG. The statistical significance of the data was evaluated
through two-tailed Student’s t-test. p-values less than or equal
to 0.05 (95% confidence level) were considered as statistically
significant differences.
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Western Blotting of GLI2/3 Proteins
FNPs, MXPs, or MNPs were pooled and lysed in RIPA buffer
containing protease inhibitors and phosphatase inhibitors (1mM
Phenylmethylsulfonyl fluoride, 1mM NaVO4, 1X complete
protease inhibitor cocktail, EDTA-free), and slightly sonicated
with a microprobe to recover chromosome bound GLI2 and
GLI3 proteins. BCA assay (Pierce) was used to measure protein
concentration of cell lysates. Proteins were boiled with 1X
Laemmli sample buffer and run on 6% SDS-PAGE for GLI2
and GLI3, or 12% SDS-PAGE for GAPDH, which later were
wet-transferred to Polyvinylidene difluoride (PVDF) membrane.
Anti-GLI2, anti-GLI3 (Polyclonal goat IgG 1:500, R&D systems)
and anti-GAPDH (FL-335, polyclonal rabbit IgG 1:4000, Santa
Cruz Biotechnology) were prepared in 1X TBST (0.1% Tween-
20)/6% nonfat milk, as well as secondary antibodies (anti-
goat and anti-rabbit, 1:10,000). Proteins were detected by
Electrochemiluminescence assay (Amersham ECL Prime, GE
Healthcare Life Science).
DNA Binding Affinity Assay
PATCHED 1 promoter oligonucleotides were designed
according to the location of a Gli binding region (GBR) at
−2549 from the TSS site (GGAAGAAGTGTCAGTGTAAG
AGTCTCCACGTGGGTGGTCAAGGCCATGGCTGCCTCAC
GG). 100 pmole of biotin-conjugated positive oligonucleotides
and complementary oligonucleotides (Integrated DNA
Technologies) were annealed in 1X TE/50 mM NaCl buffer
in a PCR cycler and incubated with Dynabeads Streptavidin
(M280, Invitrogen). FNPs, MXPs, or MNPs from day 5 control or
ta2 embryos were pooled and processed as described for Western
blotting. Cell lysates were incubated with oligonucleotides-
bound Dynabeads at 4◦C for 2 h. Beads were washed with 1 ml
RIPA buffer three times and processed for Western Blotting
analysis.
Chromatin Immunoprecipitation
FNPs, MXPs, or MNPs from day 5 control or ta2 embryos were
harvested, pooled and crosslinked in 1% formaldehyde. Tissue
was homogenized in RIPA buffer and sonicated (Bioruptor R©
Pico, Diagenode) at 5 cycles of 30 s on/45 s off. Sheared
DNA was distributed around 0.3 kb to 1 kb on 1% agarose
gel. Cell lysates were pre-cleaned with Dynabeads protein
G (ThermoFisher Scientific) and quantified by BCA assay.
Dynabeads for immunoprecipitation were blocked with 20µg/ml
Glycogen, 20µg/ml BSA, 20µg/ml yeast RNA in RIPA buffer
at 4◦C for an hour. GLI3 antibody (AF3690, R&D systems)
and pre-blocked Dynabeads Protein G were incubated with
90% of cell lysates at 4◦C overnight. 10% of cell lysates were
kept as Input. Beads were washed with IP wash buffer I (low
salt; 50 mM HEPES-KOH pH 7.5, 150mM NaCl, 1mM EDTA,
0.1% sodium deoxycholate, 1% Triton X-100), IP wash buffer
II (high salt; 50 mM HEPES-KOH pH 7.5, 500mM NaCl, 1
mM EDTA, 0.1% sodium deoxycholate, 1% Triton X-100), IP
Wash Buffer III (LiCl containing buffer; 10mM Tris-Cl pH 8.0,
250mM LiCl, 1mM EDTA, 0.5% Sodium deoxycholate, 0.5%
NP-40) and TE buffer (10 mM Tris-HCl pH 8.0, 1 mM EDTA).
ChIP samples were reverse-crosslinked by boiling with 10%
Chelex-100 (BioRad), and treated with 0.2 mg/ml Proteinase K
at 55◦C for 30 min. Immunoprecipitated DNA samples were
analyzed with quantitative real-time PCR (BioRad) with primers
to GBR of target genes. Error bars in all figures represent standard
error of the mean (S.E.M.) from five to seven independent
experiments. The statistical significance of the data was evaluated
through two-tailed Student’s t-test. p-values less than or equal
to 0.05 (95% confidence level) were considered as statistically
significant differences.
GBR Analysis
Sequences for GBRs from previous publications (Vokes et al.,
2007, 2008) were used with a custom perl script to search for
all the exact matches of the various possible sequences of the
consensus GBRs in the chicken genome. Acquired positions of
the motifs in the genome were run through a second custom
perl script to search for genes that encompass these motif sites
at a distance of 20 kb from either end. Potential GLI targets
were confirmed using chromatin-immunoprecipitation (ChIP)
assays.
RESULTS
The Avian Ciliopathic Mutant, talpid2, has
Craniofacial Anomalies Characteristic of a
Ciliopathy
To understand the transcriptional networks affected in
craniofacial ciliopathies we analyzed the talpid2 (ta2) mutant,
a naturally occurring avian ciliopathic mutant that has been
established as a model for the human craniofacial ciliopathy,
Oral-facial-digital syndrome 14 (Chang et al., 2014; Schock
et al., 2015). The ta2 craniofacial phenotype characterized by
facial and palatal clefting, micrognathia, and hypoglossia, is
fully evident at day 7 (Figure 1). Although our previous work
has characterized this phenotype (Chang et al., 2014; Schock
et al., 2015), to determine the transcriptional networks that
contribute, we first needed to identify when phenotypic onset
occurred. At day 7 the frontonasal prominence (FNP) is shorter
and wider and frequently does not fuse to adjacent prominences
(Figures 1A–B’). Two days earlier at day 5, the MXPs were
medially rotated, the nasal pits were larger, thus preventing the
proper juxtapositioning of the FNP with adjacent prominences
(Figures 1C–D’). Palatal views showed increased patency of the
naturally cleft avian secondary palate in ta2 embryos relative to
controls at day 7 (Figures 1E–F’, dotted white lines). Two days
earlier, at day 5, the dysmorphology andmalposition of theMXPs
is just becoming apparent (Figures 1G–H’). Dorsal views of the
developing lower beak showed the MNP of ta2 embryos failed
to fuse completely and had a hypoplastic tongue (hypoglossia,
dotted black line) (Figures 1I–J’, white arrow). At day 5 there
was little difference in mandibular growth between control and
ta2 MNPs (Figures 1K–L’). From phenotypic evaluations, taken
together with the fact that these anomalies were not readily
identifiable at day 4, we determined that craniofacial anomalies
were initiated at approximately day 5 of development. Thus,
to determine the molecular networks responsible for these
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FIGURE 1 | ta2 embryos have craniofacial anomalies common to craniofacial ciliopathies. (A–B’) Frontal view of whole-mount day 7 control and ta2
embryos. (C,D’) Frontal view of whole-mount day 5 control and ta2 embryos. (E–F’) Palatal view of day 7 control and ta2 embryo with the forming secondary palate
outlined (white dotted line). (G–H’) Palatal view of day 5 control and ta2 embryo. (I–J’) Dorsal view of day 7 control and ta2 mandibles with tongue outlined (black
dotted line). (K–L’) Dorsal view of day 5 control and ta2 mandibles. Facial prominences have been pseudocolored as follows: frontonasal prominence (FNP, blue),
maxillary prominence (MXP, red), and mandibular prominence (MNP, yellow). Scale bars: 1 mm (A–J’) and 650µm (K–L’).
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phenotypes we carried out our analyses in the facial prominences
of day 5 embryos.
Loss of Cilia Results in Aberrant GLI
Isoform Production
Our previous work determined that aberrant ciliogenesis in ta2
embryos disrupted the production of GLI proteins in such a
manner that there was increasedGLIFL production and decreased
GLIT production (Chang et al., 2014). The GLIFL isoform
typically goes on to function as an activator, whereas the GLIT
isoform goes on the function as a repressor. The excessive
production of GLIFL is an extraordinarily common molecular
phenotype in ciliopathies, including those with craniofacial
phenotypes (Huangfu and Anderson, 2005; Davey et al., 2006;
Tran et al., 2008; Tabler et al., 2013). To carefully exam the
differences of GLIFL and GLIT protein levels in control and ta
2
mutants, we performed Western blot analysis of GLI2 and GLI3
in the three facial prominences affected in the ta2 at day 5. We
detected a very low level of GLI2FL and a substantial amount of
GLI2T isoforms in the control facial prominences (Figure 2A).
The loss of cilia in ta2 embryos disrupted GLI processing
and altered the production of GLI2 protein isoforms. In ta2
facial prominences, we detected dramatically increased levels of
GLI2FL, and low levels of GLI2T, relative to control prominences.
We next examined the production of GLI3 isoforms. Western
blot analyses showed that, similar to GLI2FL, GLI3FL was
increased in ta2 prominences relative to controls. Contrary to
what was observed with the GLI2T, GLI3T was readily detectable
in both control and ta2 facial prominences. Specifically, ta2
MNP had less GLI3T than control MNP. These data suggested
that disrupted ciliogenesis affected the processing of GLI2 and
GLI3 in distinct manners, yet the net result was an increase
in GLIFL production. We did not observe a change in GLI1
protein levels between control and mutant embryos (Data not
shown).
Since the GLIFL isoform typically goes on to act as an
activator, these results suggest that craniofacial phenotypes in
the ta2 mutant could be caused by increased GLI activator
function leading to increased expression of GLI target genes.
To test this hypothesis, we utilized an in silico approach to
look for potential GLI target genes within the avian genome.
Using previously published sequences of GBRs (Vokes et al.,
2007, 2008) we scanned the chicken genome for possible
GLI targets. GBR positions were run through a custom perl
script to search for genes that encompass these motif sites
at a distance of 100 kb from the 5′ or 3′ end of the gene.
From this list we identified several genes known to play
a role in craniofacial development (Supplemental Table 1).
Confirmation of our in silico approach was carried out on
selected genes using ChIP assays (Supplemental Figures 1 A–D).
Through these analyses, we selected four GLI3 target genes
known to be expressed during, and have a role in, craniofacial
development: ALX4 (Beverdam et al., 2001; Mavrogiannis et al.,
2001), BMPR1A (Li et al., 2011, 2013; Saito et al., 2012),
OSR2 (Lan et al., 2001), and WIF1 (Hsieh et al., 1999; Darnell
et al., 2007). PTCH1, a known GLI target, was used as a
positive control (Supplemental Figure 1E) and IgG IP as an
antibody background control. The data were all normalized
to IgG IP percentage, and the genes with relative enrichment
>1 were considered positive for GLI3 binding. To determine
if increased production of GLI3FL in ta
2 facial prominences
correlated with increased expression of these target genes, we
performed quantitative RT-PCR (qPCR) with mRNA from facial
prominences of day 5 control and ta2 embryos (Figures 2B–E).
There was not an increase in ALX4 expression in any of
the facial prominences (Figure 2B); however, we detected a
significant decrease in ALX4 expression in the MXP. BMPR1A
expression was also not significantly increased in any of the
developing prominences (Figure 2C). No significant changes in
OSR2 expression were detected in the FNP or MNP; however,
a significant increase in expression was observed in the MXP
(Figure 2D). Finally, WIF1 expression was not changed in the
FNP, yet was significantly increased in the MXP and significantly
decreased in the MNP (Figure 2E). Taken together, these data
do not support the idea that increased production of GLI3FL
directly and uniformly results in increased expression of GLI
targets throughout the facial prominences. Additionally, these
data suggest that each facial prominence interprets aberrant GLI
production in a unique manner.
Excess Production of GLIFL Does Not
Correlate with an Increase of GLIFL
Occupancy at GBRs
For GLIFL to function as an activator, it has to occupy the
regulatory regions of GLI targets.Wewondered if lack of uniform
increases of target gene expression in ta2 embryos was due to
failure of GLIFL to recognize and occupy GBRs of target genes.
To test this hypothesis, we performed an in vitro DNA binding
assay using the PATCHED 1 (PTCH1) promoter. We synthesized
a 60 base pair biotin-labeled oligonucleotide of the PTCH1
promoter containing an endogenous GLI binding motif found
at position −2549 proximally upstream of the transcription
start site (TSS). Through high affinity of Biotin-Streptavidin
interaction, we were able to evaluate the DNA binding ability
of GLI3 isoforms by Western blot. Pre-incubation of non-
labeled PTCH1 oligonucleotides depleted GLI3 protein signals,
which confirmed the specificity of the GLI3-GBR interaction.
Under the same exposure, the affinity based pull-down assay
showed that GLI3T predominantly bound to the biotin-labeled
oligonucleotides in both control and ta2 mutants. Interestingly,
despite the high level of GLI3FL production in ta
2 embryos,
GLI3FL failed to bind to the biotin-labeled oligonucleotides
(Figures 3A,B). On the contrary, comparison between control
and ta2 embryos indicated that the amount of GLI3T binding
to the oligonucleotides correlates with the protein concentration
(Figures 3A,B). Taken together these data suggest that despite
increased GLI3FL production, target gene expression is not
increased via increased GLI activator function because GLI3FL
does not occupy the GBRs of target genes. In addition, the
predominant binding of the GLI3T repressor at GBRs supports
the idea of the threshold repression model, in which GLI targets
underwent de-repression due to the removal of GLIT repressor.
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FIGURE 2 | Excessive GLIFL production in ta
2 embryo does not correlate with increased gene activation of GLI targets. (A)Western blot of GLI2 and GLI3
proteins from the frontonasal prominence (FNP), maxillary prominence (MXP) and mandibular prominence (MNP) of day 5 control and ta2 embryos. GAPDH was used
as a loading control. (B–E) mRNA-qPCR analyses of ALX4, BMPR1A, OSR2, WIF1 from FNP, MXP, and MNP of day 5 control and ta2 embryos. The data was
normalized by the individual facial prominences of control and ta2 embryos. The asterisks indicate statistically significant differences and are assigned as followed:
*P < 0.05, **P < 0.01. Error bars are based on the standard error of the means (S.E.M.). n = 4.
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FIGURE 3 | GLI3T isoform is predominantly recruited to GBR motif of
PTCH1 promoter in vitro. (A) DNA binding affinity assay of GLI3 proteins
with frontonasal prominence (FNP), maxillary prominence (MXP), and
mandibular prominence (MNP) in day 5 control and ta2 embryos. (B) Western
blot of GLI3 proteins from the same lysates as (A). GAPDH as loading control
of cell lysates.
GLI3 Occupancy at GBRs within the
Regulatory Regions of Target Genes Is
Altered in ta2 Mutants
In vitro DNA binding affinity assays suggested that there was
not an increase of ectopic GLI3FL at GBRs of target genes
in ta2 mutants. To determine if GLI3 binding to GBRs was
altered in vivo in ta2 mutants compared to control embryos,
we next performed ChIP-qPCR (Figure 4). In ta2 mutants,
GLI3 enrichment at GBRs associated with the craniofacial genes
ALX4 and OSR2 was reduced in all facial prominences, yet
only significantly in the MXP and MNP (Figures 4A,B). GLI3
enrichment at the GBRs associated with BMPR1A and WIF1,
was also overwhelmingly reduced in facial prominences, yet only
significantly in the ta2 FNP and MXP (Figures 4C,D). GLI3
binding in the MNP of WIF1 was below detectable levels in
controls, and thus could not be evaluated. These data suggested
that GLI3 occupancy at the GBR of target genes is decreased. Our
in vitro data suggested that GLI3FL did not bind at target gene
GBRs (Figure 3). Thus, taken together these data indicate that
the observed reduction of GLI3 binding is indicative of reduced
GLI3T binding at the regulatory regions of target genes.
Reduced GLI3 binding at GBRs of GLI target genes
appeared to be a general trend in ta2 mutants, as several
other target genes expressed in the craniofacial complex
also exhibited reduced enrichment of GLI3 at associated
GBRs (Supplemental Figure 2). Thus, these data suggested
that altered expression of GLI targets could be caused by
aberrant GLI3T binding in ta
2 mutants. Interestingly, there
was not always a direct correlation with loss of GLI3T
repressor binding and increased gene expression. Furthermore,
different results among the three facial prominences examined
pointed to context—and tissue-specific regulation of GLI targets
(Supplemental Figures 1A–D). Several studies have proposed
the possibility that GLI proteins work together with co-regulators
to influence expression of targets genes (Brewster et al., 1998;
Koyabu et al., 2001; Mizugishi et al., 2001; Lee et al., 2010;
Peterson et al., 2012). To determine if target gene expression in
the craniofacial complex was influenced by the action of GLI co-
regulators, we next examined the proximity of GBRs to motifs for
potential GLI co-regulators.
Motif Analyses Identified Sequences for
Known GLI Co-Regulators Frequently
Co-Localize with GBRs
GBRs have previously been identified in close proximity
to binding motifs for other transcription factors, including
members of the bHLH, SP, and Sox families (Vokes et al.,
2008; Peterson et al., 2012; Aberger and Ruiz I Altaba, 2014).
Furthermore, the co-occupancy and cooperativity of GLI with
SOX transcription factors was previously shown to be essential
for activating neural gene expression signatures (Peterson et al.,
2012). To determine if expression of our identified GLI targets
could be influenced by the presence or absence of GLI co-
regulators, we first examined the genomic sequence around the
GBRs of our target genes for E-box, SP, and SOX binding motifs.
(Figure 5, Supplemental Figure 3). We defined the area <1 kb
upstream of the transcription start site (TSS) as the promoter
region, <20 kb away from the TSS as proximal upstream or
downstream, and <100 kb away from the TSS as distal upstream
or downstream. We analyzed the sequence surrounding GBRs
in our four selected GLI target genes for sequences predictive
of E-box, SP, and SOX binding. All four of our identified GLI
target genes contained at least one motif cluster containing a
GBR, E-box, SP, and SOX binding site within 1 kb of each other
(Figures 5A–D). Several other clusters containing three of the
four motifs were also identified (Figures 5A–C; red box). The
close proximity of these binding motifs suggested that expression
of GLI targets in the developing craniofacial complex could be
influenced by the cooperative function of GLI isoforms and
co-regulator proteins.
GLI Co-Regulators Have a Prominence
Specific Expression Pattern That Changes
When Primary Cilia Are Lost
Several transcription factors synergistically cooperate with GLI
proteins to influence GLI target gene expression (Aberger and
Ruiz I Altaba, 2014). Their co-occupancy at the promoter of GLI
targets is required for the optimal activation/repressor. ChIP-
based, high-throughput analyses uncovered several transcription
factor motifs located close to GBRs in the cis-regulatory modules
of GLI targets. Specifically, binding sequences for Sox (Peterson
et al., 2012), bHLH (Lee et al., 2010), and SP proteins (Vokes
et al., 2008) have been shown to exist in very close proximity
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FIGURE 4 | GLI3 occupancies at the GBRs of GLI targets is reduced in ta2 mutant. (A–D) ChIP-qPCR analyses of GLI3 precipitated with GLI binding regions
of (A) ALX4, (B) BMPR1A, (C) OSR2, and (D) WIF1 in control and ta2 facial prominences. The asterisks indicate statistic significant difference and are labeled as
followed: *P < 0.05, **P < 0.01, ***P < 0.001 . Error bars are based on the standard error of the means (S.E.M.). n = 5.
to GBRs. Our in silico analyses confirmed these sequences exist
in near GBRs in four previously identified GLI-targets. We
hypothesized that differential expression of these co-regulators
could contribute to the differential gene expression of GLI targets
in both control and ta2 mutant embryos. We first investigated
the expression of genes that could bind to motifs found in
close proximity to GBRs, specifically SOX8, SP3, and HAND2
(Figures 6A–C). SOX8 expression was significantly reduced in
the FNP and MXP of ta2 mutants, yet was not significantly
altered in the MNP (Figure 6A). SP3 expression was significantly
increased in ta2 MNP, yet not changed in the FNP and MXP
(Figure 6B).HAND2 expression was reduced in theMXP, but not
significantly changed between control and ta2 FNPs and MNPs
(Figure 6C). Thus, differential expression of GLI co-regulators
could possibly contribute to altered target gene expression in ta2
mutants and explain why changes in GLIFL and GLIT isoforms
do not uniformly or directly correlate with changes in target gene
expression.
Our previous analyses indicate that GLI target gene expression
changed in a prominence specific manner (Chang et al.,
2014). We wondered if differential expression of potential
GLI co-regulators could contribute to this prominence-specific
expression changes. SOX8 was robustly expressed within the
FNP, with levels significantly higher than those in the MXP
or MNP (Figure 6A’). SP3 was more robustly expressed in the
MXP and MNP, relative to the FNP (Figure 6B’). HAND2 was
robustly and exclusively expressed in the MNP (Figure 6C’).
Thus, each of these potential co-regulators has a prominences
specific expression pattern that could differentially influence GLI
target gene expression. Collectively, the proximity of binding
motifs, coupled with the differential expression of these co-
regulators could possibly contribute to altered expression of GLI
targets in ta2 embryos.
DISCUSSION
Craniofacial ciliopathies are a rapidly growing group of disorders
that severely impact craniofacial growth and development.
Currently, there are little to no therapeutic options for these
conditions. Although the molecular mechanism behind these
disorders remains nebulous, many ciliopathies have aberrant
production of GLIFL and GLIT isoforms. (Huangfu and
Anderson, 2005; Davey et al., 2006; Tran et al., 2008; Tabler et al.,
2013; Chang et al., 2014). Herein, we attempted to identify the
mechanism by which aberrant GLI protein production impacts
craniofacial development. To do so we used the avian ta2 model,
which has recently been characterized as a bona fide model for
the human craniofacial ciliopathy Orofacial-digital syndrome 14
(Schock et al., 2015). In silico and ChIP assays identified GLI
target genes in the avian genome that play a role in craniofacial
development. RT-qPCR of mRNA levels verified some significant
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FIGURE 5 | Schematic diagram of co-regulator motif clusters near GBRs of ALX4, OSR2,WIF1 and BMPR1A. In silico analyses predict location of GLI (blue
circle), E-box (magenta triangle), SP (red rectangle), and SOX (yellow circle) sites in GLI target genes (A) ALX4, (B) OSR2, (C) WIF1, (D) BMPR1A. We defined
5′-untranslated region (UTR), gene and 3′-UTR as intragenic region, <1 kb upstream of transcription start site (TSS) is promoter region, 1–20 kb away from TSS as
proximal regulatory region, and <100 kb away from TSS as distal regulatory region. The numbers labeled below the symbols indicate the positions of the motifs
according to the distance away from TSS sites. The position upstream of TSS site is assigned a negative symbol. The area amplified by primer sets used for
ChIP-quantitative PCRs are labeled above the specific GLI binding motif (red line). Clusters of four motifs are highlighted in a black box, clusters of three motifs are
highlighted in a red box.
changes in the expression of these GLI targets in the developing
facial prominences, yet there was not a clear, linear relationship
between changes in GLI isoform production and target gene
expression. Motif cluster analysis supported the hypothesis that
GLI proteins work in concert with co-regulators. GBRs associated
with GLI target genes were found to be situated within 1000
bp of binding motifs for several, previously identified GLI
co-regulators. Differential expression within developing facial
prominences of predicted co-regulators supported a hypothesis
in which expression of GLI target genes is dependent upon the
cooperative function of GLI isoforms and co-regulator proteins.
Together, these data provide a better understanding of the
complex nature of GLI-mediated transcription that occurs in
normal and ciliopathic craniofacial development.
GLI Binding Regions Are Present
throughout the Avian Genome in Genes
That Affect Craniofacial Development
Work in other species has identified GBRs and examined the role
of GLI proteins as transcription factors that affect gene expression
in numerous signaling pathways (Vokes et al., 2007, 2008).
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FIGURE 6 | Prominence-specific expression of SOX8, SP3, and Hand2. Quantitative RT-PCR analyses of transcription factors (SOX8, SP3 and Hand2) based
on the comparison between control and ta2 embryos (A–C) or individual facial prominences (A’–C’). The asterisks indicate statistical significance and are labeled as
followed: *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001. Error bars are based on the standard error of the means (S.E.M.). n = 4.
Three models currently exist to explain GLIFL/GLIT function
(Falkenstein and Vokes, 2014). First the GLIFL::GLIT ratio
sensing model suggest that the relative levels of GLIFL to GLIT is
integrated and results in graded levels of transcription of targets.
This model suggests that response to changes in ratio, rather
than concentration, affect target gene expression. The threshold
activation model suggests that, rather than ratio of GLIFL::GLIT,
a threshold-specific concentration of GLIFL activates target gene
expression (Oosterveen et al., 2012). The threshold repression
model depends on the removal of the GLIT repressor from
target genes, allowing for transcriptional activation by other
transcription factors to initiate gene expression. From our results,
mRNA expression of most target genes was not dramatically
altered despite excessive GLIFL production in ta
2 mutant,
indicating that the ratio sensing model cannot explain our
observation in ta2 mutant. Secondly, the accumulated GLI3FL
in the nucleus was expected to bind and activate target gene
in the threshold activation model; however, instead we found
reduced occupancy of GLI3 at target genes, along with lack
of detectable GLIFL binding to GBRs (Figures 3, 4), suggesting
that a dysfunctional GLIFL that fails to promote GLIA-mediated
activation is produced under ciliopathic conditions. Thus, these
data do not support the threshold activation model for GLIFL
function. Conversely, our results showed that reduced GLIT
production could lead to a de-repression of target genes and
potentially a gene activation, when the required transcription
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factors are available. The threshold repression model seems to be
more applicable to the observation owing to less GLI3 occupancy
and the failure of GLIFL to GLIT conversion. A more in depth
understanding of GLI mechanisms of action will require tools
with the ability to definitively decipher between GLIFL and GLIT
in vivo.
Excessive GLIFL Production Does Not
Equate to Increased GLIA Activity in Ciliary
Mutants
A number of disorders identified as ciliopathies have craniofacial
abnormalities including Oral-facial-digital syndrome, Joubert
syndrome, Bardet-Biedl syndrome, Meckel-Gruber syndrome,
Ellis-van Creveld syndrome (Zaghloul and Brugmann, 2011).
The phenotypes for syndromes such as these, while not identical,
do have several phenotypes indicative of aberrant SHH signaling
including widening of the midface, cleft lip/palate, micrognathia,
craniosynostosis and oral/dental anomalies (Zaghloul and
Brugmann, 2011). Increased production of GLIFL isoforms
has been observed in several ciliary mutants (Huangfu and
Anderson, 2005; Liu et al., 2005; Humke et al., 2010), thus
a common interpretation of these data is that ciliopathic
phenotypes were due to either increased activator function or
skewed GLIFL::GLIT ratio in favor of GLIFL. Despite these
common interpretation regarding the molecular mechanism
causing ciliopathic phenotypes, examination of subsequent levels
of GLI processing, binding, and transcriptional function in ciliary
mutants has not been performed.
Our studies are among the first to examine how and if GLI
proteins function in the developing craniofacial complex of
ciliary mutants; however, some questions remain regarding the
mechanistic reasons as to why GLIFL appears not to function
in ciliary mutants. Prior to processing, GLI proteins associate
with Suppressor of Fused (SUFU), a conserved protein known
to regulate the activity of GLI proteins via modulating GLI
processing, stabilization and subcellular localization (Barnfield
et al., 2005; Humke et al., 2010; Tukachinsky et al., 2010; Wang
et al., 2010). In the presence of a SHH signal, the SUFU-
GLIFL complex traffics through the cilium (Eggenschwiler and
Anderson, 2007). Activated ciliary SMO then works through
KIF7 to promote the dissociation of the inhibitory SUFU-
GLIFL complex (Humke et al., 2010; Tukachinsky et al.,
2010; Li et al., 2012). Free GLIFL is then processed into an
activator and moves to the nucleus to activate downstream
targets. In the absence of the SHH ligand, SMO is not
translocated into the cilium and thus cannot antagonize SUFU.
SUFU remains in complex with GLIFL, GLIFL is proteolytically
processed into GLIT and the SUFU-GLIT complex moves to the
nucleus where it recruits the Sap18-Sin3 co-repressor complex
to repress GLI target genes (Ding et al., 1999; Kogerman
et al., 1999; Cheng and Bishop, 2002; Paces-Fessy et al.,
2004). Furthermore, our recent work with the murine ciliary
mutant, Kif3fl/fl;Wnt1-Cre shows increased SUFU production
and nuclear localization, as well as enhanced association of
SUFU with GLI3 (Chang et al., in press). We hypothesize
a similar mechanism is at play in ta2 mutants. Specifically,
excessive GLIFL produced in ta
2 mutants cannot dissociate
from SUFU because the complex cannot undergo ciliary
trafficking. We further hypothesize that lack of dissociation
prevents GLIFL from occupying GBRs and directly activating
target gene transcription. Our future studies will address the
association of GLIFL and SUFU in ta
2 mutants and determine
if their maintained association contributes to ciliopathic
phenotypes.
GLI-Binding to Target Genes Occurs in a
Prominence Specific Manner
Frequently the craniofacial complex is thought of as a singular
organ system; however, the prominences that make up the face
develop independently prior to their fusion. There is evidence
to support that these prominences have distinct molecular
profiles and develop as separate developmental fields (Brugmann
et al., 2007). Our ChIP-qPCR results detected differential GLI
binding to target genes in facial prominences of control embryos
(Figures 2B–D). Further, the expression of co-regulators also
followed a prominence specific pattern in both control and ta2
embryos (Figures 6A’–C’). These data supported the hypothesis
that during normal development, as well as when cilia are lost,
each facial prominence uses a unique mechanism to transduce
a SHH-dependent GLI signal. Based on our examination of co-
regulators, we hypothesize that there is a combinatorial code of
GLI isoforms and co-regulators that work together to precisely
regulate target gene expression. Thus, when cilia are lost and
GLI production is altered, target gene expression is dictated by
how the combinatorial code of remaining GLI isoforms and
co-regulators function together.
In sum, our data suggest that the increased or decreased
production of GLI isoforms alone is not sufficient to explain
how target gene expression will be altered. To understand
the molecular mechanisms responsible for ciliopathic, GLI-
mediated phenotypes, future studies will have to account for
tissue specificity, the presence or absence of co-regulators and the
mode of GLI function (activation or de-repression) to begin to
address this process.
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Supplementary Figure 1 | GLI3 binding to GLI targets is confirmed by ChIP.
ChIP-qPCR analyses of GLI3 precipitated with GLI binding regions of ALX4
(A), BMPR1A (B), OSR2 (C), WIF1 (D), and PTCH1 (E) in facial prominences
of control embryo. Error bars are based on the standard error of the means
(S.E.M.). n = 3.
Supplementary Figure 2 | ChIP-qPCR analyses of GLI3 precipitated with
GLI binding regions of PTCH1 (A), TFAP2A (B), CTNNB1 (C),WNT2B (D),
DKK1 (E), FGFR (F), BMP2 (G), BMP4 (H), BMP7 (I), and EPHA4 (J) in
control and ta2 facial prominences. Error bars are based on the standard error
of the means (S.E.M.). n = 3.
Supplementary Figure 3 | The schematic of the clusters of transcription
factor motifs in GBRs of GLI targets. The in silico analyses of GLI (blue circle),
E-box (magenta triangle), SP site (red rectangle), and SOX site (yellow circle) in the
GBRs of GLI targets. We defined 5′-untranslated region (UTR), gene and 3′-UTR
as intragenic region, <1 kb upstream of transcription start site (TSS) is promoter
region, 1–20 kb away from TSS as proximal regulatory region, and <100 kb away
from TSS as distal regulatory region. The numbers labeled below the symbols
indicate the positions of the motifs according to the distance away from TSS sites.
The position at the upstream of TSS site is assigned a negative symbol. The
primer sets used for ChIP-quantitative PCRs are labeled above the specific GLI
binding motif (red line). Clusters of four motifs are highlighted in a black box,
clusters of three motifs are highlighted in a red box.
Supplementary Table 1 | Identified Gli target genes.
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